Mood swings in patients with Crohn's disease: Incidence and associated factors;Oscilação do humor em pacientes com doença de Crohn: Incidência e fatores associados

Revista da Associacao Medica Brasileira

Volumn 58, Issue 4, 2012, Pages 481-488

  de Lima, Flávia D'Agosto Vidal ^a   Ribeiro, Tarsila Campanha da Rocha ^b   Chebli, Liliana Andrade ^b   Pace, Fábio Heleno de Lima ^b   Chaves, Leonardo Duque de Miranda ^c   Ribeiro, Mário Sérgio ^a   Chebli, Julio Maria Fonseca ^b  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UFJG   (Brazil)

Author keywords

Croh's disease; Depression and anxiety; Mood swings; Psychology

Indexed keywords

EID: 84866115498     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302012000400021     Document Type: Article

References (56)

1. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut.1996;39(5):690-7.
2. Markesich DC, Sawai ET, Butel JS, Graham DY. Investigations on etiology of Crohn's disease. Humoral immune response to stress (heat shock) proteins. Dig Dis Sci.1991;36(4):454-60.
3. Ringel Y, Drossman DA. Psychosocial aspects of Crohn's disease. Surg Clin North Am. 2001;81(1):231-52.
4. Friedman S. General principles of medical therapy of inflammatory bowel disease. Gastroenterol Clin North Am. 2004;33(2):191-208.
5. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504-17.
6. Kappelman MD, Rifas-Shiman SL, Kleinman K, Dan Ollendorf, Bousvaros A, Richard JG et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5(12):1424-9.
7. Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001;7(3):260-70.
8. Gaburri PD, Chebli JM, Castro LE, Ferreira JO, Lopes MH, Ribeiro AM et al. Epidemiology, clinical features and clinical course of Crohn's disease: a study of 60 cases. Arq Gastroenterol. 1998;35(4):240-6.
9. Souza MH, Troncon LE, Rodrigues CM, Viana CF, Onofre PH, Monteiro RA et al. Trends in the occurrence (1980-1999) and clinical features of Crohn's disease and ulcerative colitis in a university hospital in southeastern Brazil. Arq Gastroenterol. 2002;39(2):98-105.
10. Mardini HE, Kip KE, Wilson JW. Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci. 2004;49(3):492-7.
11. Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54(10):1481-91.
12. Porcelli P, Zaka S, Centonze S, Sisto G. Psychological distress and levels of disease activity in inflammatory bowel disease. Ital J Gastroenterol. 1994;26(3):111-5.
13. Sewitch MJ, Abrahamowicz M, Bitton A, Daly D, Wild GE, Cohen A et al. Psychological distress, social support, and disease activity in patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96(5):1470-9.
14. North CS, Alpers DH, Helzer JE, Spitznagel EL, Clouse RE. Do life events or depression exacerbate inflammatory bowel disease? A prospective study. Ann Intern Med. 1991;114(5):381-6.
15. Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis. 2007;13(2):225-34.
16. Walker EA, Gelfand MD, Gelfand AN, Creed F, Katon WJ. The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. Gen Hosp Psychiatry. 1996;18(4):220-9.
17. Persoons P, Vermeire S, Demyttenaere K, Fischler B, Vandenberghe J, Van Oudenhove L et al. The impact of major depressive disorder on the short-and long-term outcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther. 2005;22(2):101-10.
18. Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 2004;66(1):79-84.
19. Maunder RG. Evidence that stress contributes to inflammatory bowel disease: evaluation, synthesis, and future directions. Inflamm Bowel Dis. 2005;11(6):600-8.
20. Lashner B. Clinical features, laboratory findings and course of Crohn's disease. 5th ed. Chicago: W.B. Saunders; 2005.
21. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6(1):8-15.
22. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70(3):439-44.
23. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand R et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340(18):1398-405.
24. Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut. 1987;28(12):1600-4.
25. Gorenstein C, Andrade L. Validation of a portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz J Med Biol Res. 1996;29(4):453-7.
26. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4(5):561-71.
27. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69-77.
28. Botega NJ, Bio MR, Zomignani MA, Garcia C Jr, Pereira WA. Mood disorders among inpatients in ambulatory and validation of the anxiety and depression scale HAD. Rev Saúde Pública. 1995;29(5):355-63.
29. Freud S. Sobre o mecanismo psíquico dos fenômenos histéricos. São Paulo: Imago; 2004. v.2.
30. Filho JM. Concepção psicossomática: visão atual. 9a ed. São Paulo: Casa do Psicólogo; 2002.
31. Skinner BF. Sobre o Behaviorismo. 13a ed. São Paulo: Editora Pensamento-Cultrix; 2011. v.1.
32. Day TA. Defining stress as a prelude to mapping its neurocircuitry: no help from allostasis. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(8):1195-200.
33. Zozaya J. El medico y el paciente en el contexto de la enfermidad cronica. Rev Centro Policlan Valência. 1985;3(1):117-9.
34. Frasure-Smith N, Lesperance F, Talajic M. The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol. 1995;14(5):388-98.
35. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91(4):999-1005.
36. Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet. 1999;354(9187):1331-6.
37. Mc Farlane AC, Brooks PM. An analysis of the relationship between psychological morbidity and disease activity in rheumatoid arthritis. J Rheumatol. 1988;15(6):926-31.
38. Robertson DA, Ray J, Diamond I, Edwards JG. Personality profile and affective state of patients with inflammatory bowel disease. Gut. 1989;30(5):623-6.
39. Talal AH, Drossman DA. Psychosocial factors in inflammatory bowel disease. Gastroenterol Clin North Am. 1995;24(3):699-716.
40. North CS, Alpers DH. A review of studies of psychiatric factors in Crohn's disease: etiologic implications. Ann Clin Psychiatry.1994;6(2):117-24.
41. Greene BR, Blanchard EB, Wan CK. Long-term monitoring of psychosocial stress and symptomatology in inflammatory bowel disease. Behav Res Ther. 1994;32(2):217-26.
42. Kurina LM, Goldacre MJ, Yeates D, Gill LE. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health. 2001;55(10):716-20.
43. Levenstein S, Prantera C, Varvo V, Scribano ML, Andreoli A, Luzi C et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol. 2000;95(5):1213-20.
44. North CS, Clouse RE, Spitznagel EL, Alpers DH. The relation of ulcerative colitis to psychiatric factors: a review of findings and methods. Am J Psychiatry. 1990;147(8):974-81.
45. Goodhand JR, Wahed M Mawdsley JE, Farmer AD, Aziz, Q, Rampton DS. Mood disorders in inflammatory bowel disease: Relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis. 2012. [in press]
46. Andrade, L, Walters EE, Gentil V, Laurenti R. Prevalence of ICD-10 mental disorders in a catchment area in the city of Sao Paulo, Brazil. Soc Psychiatry Psychiatr Epidemiol. 2002;37(7):316-25.
47. Kessler RC, Mc Gonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19.
48. Brandi MT, Ribeiro MS, Chebli LA, Franco MB, Pinto AL, Gaburri PD et al. Psychological distress in Brazilian Crohn's disease patients: screening, prevalence, and risk factors. Med Sci Monit. 2009;15(8):PH101-08.
49. Harman JS, Rollman BL, Hanusa BH, Lenze EJ, Shear MK. Physician office visits of adults for anxiety disorders in the United States, 1985-1998. J Gen Intern Med. 2002;17(3):165-72.
50. Grant BF, Hasin DS, Stinson FS, Dawson DA, June Ruan W, Goldstein RB et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2005;35(12):1747-59.
51. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-27.
52. Seedat S, Scott KM, Angermeyer MC, Berglund P, Bromet EJ, Brugha T et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry. 2009;66(7):785-95.
53. Reavley NJ, Jorm AF, Cvetkovski S, Mackinnon AJ. National depression and anxiety indices for Australia. Aust N Z J Psychiatry. 2011;45(9):780-7.
54. Houssami N, Irwig L, Simpson JM, McKessar M, Blome S, Noakes J. The influence of clinical information on the accuracy of diagnostic mammography. Breast Cancer Res Treat. 2004;85(3):223-8.
55. Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Andreoli A et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol. 1994;89(8):1219-25.
56. Bitton A, Sewitch MJ, Peppercorn MA, Edwardes B, Shah S, Ransil B et al. Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol. 2003;98(10):2203-8.